Biomineralization |
BPNs-GelMA |
Promoted the expression of osteogenesis-related genes and accelerated bone repair. |
[10] |
|
BPNs-OPF |
Exhibited a controllable degradation rate and phosphate release capacity. Enhanced the adhesion, proliferation, and osteogenic differentiation of pre-osteogenic cells. |
[73] |
|
PDA@BPNs-PLLA |
Improved the stability of the BPN and promoted osteogenic differentiation. |
[74] |
|
L-NH-BP-PLCL |
Promoted the proliferation and osteogenic differentiation of mesenchymal. |
[72] |
|
GO@BP-PPF |
Promoted cell adhesion and osteogenic differentiation. |
[75] |
Vascularized Osteogenesis |
Deferoxamine/BP-GelMA |
Promoted local expression of CD31 and positively affected a vascular repair. |
[76] |
|
VEGF@BPNs-DNA hydrogel |
Continuous release of VEGF. Accelerated vascular regeneration and bone regeneration. |
[77] |
|
BP@Mg double-layer scaffold |
Promoted early nerve regeneration and angiogenesis in the process of bone regeneration. |
[78] |
Photothermal Osteogenesis |
BP/IBU@SA-PLLA |
Significantly high photothermal conversion efficiency and photothermal-responsive intelligent drug release performance. |
[79] |
|
SrCl2/BPNs-PLGA |
Remarkable cell compatibility and degradation capability. Remarkably controlled release of strontium ions. |
[18] |
|
BP@HA/SiO2-PLLA |
The photothermal effect promoted the release of elements, thereby achieving accelerated osteogenesis. |
[80] |
Antibacterial |
BPNs-GelMA |
The hydrogel could be heated up to 55.3 ℃ and showed efficient antibacterial and antitumor effects. |
[81] |
|
BPNs/HA coating |
Remarkable photothermal conversion capability and good anti-biofilm properties. |
[82] |
|
BP@Mg-GelMA |
Remarkable antibacterial capability and induced innerved bone regeneration. |
[83] |
Antitumor |
BPNs -BG scaffold |
Remarkable photothermal antitumor activity and osteogenic induction ability. |
[84] |
|
BP/doxorubicin hydrochloride/PDA coating |
NIR/pH dual controlled antitumor drug release and high antibacterial activity. |
[85] |